This article provides a comprehensive analysis of retrospective and prospective methodologies for assessing premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), tailored for researchers, clinical scientists, and drug development professionals.
This article provides a comprehensive analysis for researchers and drug development professionals on the application of hypogonadal and hypergonadal models to elucidate the effects of oral contraceptives (OCs).
This article provides a comprehensive analysis of step-up and step-down ovulation induction protocols, focusing on their distinct hormonal response profiles and clinical outcomes.
This article provides a detailed comparative analysis of two prominent Anti-Müllerian Hormone (AMH) assays: the manual AMH Gen II ELISA and the fully automated Elecsys Cobas AMH.
This article provides a comprehensive analysis of the key confounding variables that complicate the screening and research of cyclical mood disorders, with a specific focus on cyclothymic disorder and bipolar...
This article provides a comprehensive framework for researchers and drug development professionals to optimize the number and timing of experimental assessments.
This article provides a comprehensive analysis of the sources and solutions for analytical variability in hormone immunoassays, a critical challenge for researchers and drug development professionals.
Accurate hormone measurement is critical for reliable research and drug development, yet preanalytical variability during blood collection and processing remains a significant source of error.
This article addresses the critical methodological challenge of false-positive retrospective reports in premenstrual disorder research, a significant concern for etiologic studies and drug development.
This article provides a comprehensive framework for establishing hormone level-based inclusion criteria in clinical research and drug development.